Differential impact of the COVID-19 pandemic on primary care utilization related to common mental disorders in four European countries: A retrospective observational study.

COVID-19 common mental disorder containment measures primary healthcare time series analysis

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2022
Historique:
received: 15 09 2022
accepted: 13 12 2022
entrez: 26 1 2023
pubmed: 27 1 2023
medline: 27 1 2023
Statut: epublish

Résumé

The COVID-19 pandemic is commonly believed to have increased common mental disorders (CMD, i.e., depression and anxiety), either directly due to COVID-19 contractions (death of near ones or residual conditions), or indirectly by increasing stress, economic uncertainty, and disruptions in daily life resulting from containment measure. Whereas studies reporting on initial changes in self-reported data frequently have reported increases in CMD, pandemic related changes in CMD related to primary care utilization are less well known. Analyzing time series of routinely and continuously sampled primary healthcare data from Sweden, Norway, Netherlands, and Latvia, we aimed to characterize the impact of the pandemic on CMD recorded prevalence in primary care. Furthermore, by relating these changes to country specific time-trajectories of two classes of containment measures, we evaluated the differential impact of containment strategies on CMD rates. Specifically, we wanted to test whether school restrictions would preferentially affect age groups corresponding to those of school children or their parents. For the four investigated countries, we collected time-series of monthly counts of unique CMD patients in primary healthcare from the year 2015 (or 2017) until 2021. Using pre-pandemic timepoints to train seasonal Auto Regressive Integrated Moving Average (ARIMA) models, we predicted healthcare utilization during the pandemic. Discrepancies between observed and expected time series were quantified to infer pandemic related changes. To evaluate the effects of COVID-19 measures on CMD related primary care utilization, the predicted time series were related to country specific time series of levels of social distancing and school restrictions. In all countries except Latvia there was an initial (April 2020) decrease in CMD care prevalence, where largest drops were found in Sweden (Prevalence Ratio, PR = 0.85; 95% CI 0.81-0.90), followed by Netherlands (0.86; 95% CI 0.76-1.02) and Norway (0.90; 95% CI 0.83-0.98). Latvia on the other hand experienced increased rates (1.25; 95% CI 1.08-1.49). Whereas PRs in Norway and Netherlands normalized during the latter half of 2020, PRs stayed low in Sweden and elevated in Latvia. The overall changes in PR during the pandemic year 2020 was significantly changed only for Sweden (0.91; 95% CI 0.90-0.93) and Latvia (1.20; 95% CI 1.14-1.26). Overall, the relationship between containment measures and CMD care prevalence were weak and non-significant. In particular, we could not observe any relationship of school restriction to CMD care prevalence for the age groups best corresponding to school children or their parents. Common mental disorders prevalence in primary care decreased during the initial phase of the COVID-19 pandemic in all countries except from Latvia, but normalized in Norway and Netherlands by the latter half of 2020. The onset of the pandemic and the containment strategies were highly correlated within each country, limiting strong conclusions on whether restriction policy had any effects on mental health. Specifically, we found no evidence of associations between school restrictions and CMD care prevalence. Overall, current results lend no support to the common belief that the pandemic severely impacted the mental health of the general population as indicated by healthcare utilization, apart from in Latvia. However, since healthcare utilization is affected by multiple factors in addition to actual need, future studies should combine complementary types of data to better understand the mental health impacts of the pandemic.

Sections du résumé

Background UNASSIGNED
The COVID-19 pandemic is commonly believed to have increased common mental disorders (CMD, i.e., depression and anxiety), either directly due to COVID-19 contractions (death of near ones or residual conditions), or indirectly by increasing stress, economic uncertainty, and disruptions in daily life resulting from containment measure. Whereas studies reporting on initial changes in self-reported data frequently have reported increases in CMD, pandemic related changes in CMD related to primary care utilization are less well known. Analyzing time series of routinely and continuously sampled primary healthcare data from Sweden, Norway, Netherlands, and Latvia, we aimed to characterize the impact of the pandemic on CMD recorded prevalence in primary care. Furthermore, by relating these changes to country specific time-trajectories of two classes of containment measures, we evaluated the differential impact of containment strategies on CMD rates. Specifically, we wanted to test whether school restrictions would preferentially affect age groups corresponding to those of school children or their parents.
Methods UNASSIGNED
For the four investigated countries, we collected time-series of monthly counts of unique CMD patients in primary healthcare from the year 2015 (or 2017) until 2021. Using pre-pandemic timepoints to train seasonal Auto Regressive Integrated Moving Average (ARIMA) models, we predicted healthcare utilization during the pandemic. Discrepancies between observed and expected time series were quantified to infer pandemic related changes. To evaluate the effects of COVID-19 measures on CMD related primary care utilization, the predicted time series were related to country specific time series of levels of social distancing and school restrictions.
Results UNASSIGNED
In all countries except Latvia there was an initial (April 2020) decrease in CMD care prevalence, where largest drops were found in Sweden (Prevalence Ratio, PR = 0.85; 95% CI 0.81-0.90), followed by Netherlands (0.86; 95% CI 0.76-1.02) and Norway (0.90; 95% CI 0.83-0.98). Latvia on the other hand experienced increased rates (1.25; 95% CI 1.08-1.49). Whereas PRs in Norway and Netherlands normalized during the latter half of 2020, PRs stayed low in Sweden and elevated in Latvia. The overall changes in PR during the pandemic year 2020 was significantly changed only for Sweden (0.91; 95% CI 0.90-0.93) and Latvia (1.20; 95% CI 1.14-1.26). Overall, the relationship between containment measures and CMD care prevalence were weak and non-significant. In particular, we could not observe any relationship of school restriction to CMD care prevalence for the age groups best corresponding to school children or their parents.
Conclusion UNASSIGNED
Common mental disorders prevalence in primary care decreased during the initial phase of the COVID-19 pandemic in all countries except from Latvia, but normalized in Norway and Netherlands by the latter half of 2020. The onset of the pandemic and the containment strategies were highly correlated within each country, limiting strong conclusions on whether restriction policy had any effects on mental health. Specifically, we found no evidence of associations between school restrictions and CMD care prevalence. Overall, current results lend no support to the common belief that the pandemic severely impacted the mental health of the general population as indicated by healthcare utilization, apart from in Latvia. However, since healthcare utilization is affected by multiple factors in addition to actual need, future studies should combine complementary types of data to better understand the mental health impacts of the pandemic.

Identifiants

pubmed: 36699500
doi: 10.3389/fpsyt.2022.1045325
pmc: PMC9868724
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1045325

Informations de copyright

Copyright © 2023 Flodin, Sörberg Wallin, Tarantino, Cerchiello, Mladá, Kuklová, Kondrátová, Parimbelli, Osika, Hollander and Dalman.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Brain Behav. 2021 Aug;11(8):e2264
pubmed: 34213091
BMC Psychiatry. 2021 Nov 20;21(1):586
pubmed: 34800997
BJPsych Open. 2021 Nov 17;7(6):e213
pubmed: 34784994
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Lancet Public Health. 2020 Oct;5(10):e543-e550
pubmed: 32979305
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
BMJ Open. 2021 Mar 30;11(3):e046365
pubmed: 33785494
Clin Psychol Psychother. 2022 Jul;29(4):1342-1354
pubmed: 35068003
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
BMC Health Serv Res. 2022 Feb 26;22(1):263
pubmed: 35219328
PLoS Med. 2021 Nov 23;18(11):e1003854
pubmed: 34813591
Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
J Psychiatr Res. 2021 Nov;143:43-49
pubmed: 34450524
Lancet Public Health. 2021 Feb;6(2):e124-e135
pubmed: 33444560
Lancet Reg Health Eur. 2021 Mar;2:100020
pubmed: 33870246
Scand J Public Health. 2022 Feb;50(1):26-32
pubmed: 34100665
Nord J Psychiatry. 2020 Jan;74(1):60-68
pubmed: 31553274
Lancet Psychiatry. 2022 Feb;9(2):137-150
pubmed: 35026139
Eur J Epidemiol. 2022 Feb;37(2):167-172
pubmed: 35083601
Health Aff (Millwood). 2022 Apr;41(4):573-580
pubmed: 35377763
Lancet Psychiatry. 2021 Jul;8(7):610-619
pubmed: 33965057
Int J Environ Res Public Health. 2022 Feb 16;19(4):
pubmed: 35206447
Lancet Psychiatry. 2020 Jul;7(7):567-568
pubmed: 32502467
BMJ Open. 2022 Apr 8;12(4):e057866
pubmed: 35396302

Auteurs

Pär Flodin (P)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Alma Sörberg Wallin (A)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Barbara Tarantino (B)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Paola Cerchiello (P)

Department of Economics and Management, University of Pavia, Pavia, Italy.

Karolína Mladá (K)

Department of Public Mental Health, National Institute of Mental Health, Klecany, Czechia.
Department of Psychiatry, Faculty of Medicine, University Hospital in Pilsen, Charles University, Prague, Czechia.

Marie Kuklová (M)

Department of Public Mental Health, National Institute of Mental Health, Klecany, Czechia.
Department of Demography and Geodemography, Faculty of Science, Charles University, Prague, Czechia.

Lucie Kondrátová (L)

Department of Public Mental Health, National Institute of Mental Health, Klecany, Czechia.

Enea Parimbelli (E)

Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Telfer School of Management, University of Ottawa, Ottawa, ON, Canada.

Walter Osika (W)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
Department of Neurobiology, Care Sciences and Society, Center for Social Sustainability, Karolinska Institutet, Stockholm, Sweden.

Anna-Clara Hollander (AC)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Christina Dalman (C)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Center for Epidemiology and Community Medicine, Stockholm, Sweden.

Classifications MeSH